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ABSTRACT 
 
The present study aims to evaluate the antifungal activity of Amygdalus eburnea Spach. (Rosaceae family) extracts 
against some fungi strains. Antifungal effects of A. eburnea were performed using Minimum Inhibitory 
Concentration (MIC) methods on Aspergillus flavus (ATTCC 15546) and Candida albican (ATCC 10321).  Both 
aqueous and menthanolic extract of A. eburnea at all concentration demonstrated fungistatic activity against the 
tested fungi from week to potent with the MIC ranging from 5.33 to 9.33 mg/mL and 7.3 to 13.33 mg/mL, 
respectively. To conclude, the obtained findings demonstrated that A. eburnean extracts were found to be more 
active against some pathogenic fungi strains and thus provided the evidence for its traditional use value and it is 
suitable substitute for treatment of fungi infections. 
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INTRODUCTION 
 
Nowadays, there has been an increasing incidence of fungal infections because of growth in immunocompromised 
people, such as HIV ⁄ AIDS patients [1, 2]. Fungal infections are usually related to Candida, Aspergillus and 
Cryptococcus species but those due to Candida species indicate the main opportunistic fungal infections worldwide, 
leading to high morbidity and mortality in the population [3, 4]. Current treatments of fungal infections are 
numerous, but, a few classes of antifungal drugs are currently available for treatment of infections in order to some 
limitations such as the high toxicity, the emergence of drug resistance, pharmacokinetic deficiencies, and/or 
insufficiencies in their antifungal activities [5, 6]. These reasons emphasize the urgent need for development of new 
effective treatment alternatives. Plant extracts and plant-derived compounds, due to having fewer side effects, low 
cost and high availability, are valuable sources that are commonly used to treat a wide range of disease conditions 
including infectious diseases [6-8]. One of these interesting plants is Amygdalus eburnea Spach. (called “Ghosk” in 
Persian) from family of Rosaceae as a type of almond which is naturally grown and distributed in Iran [9] In folk 
Iranian medicine A. eburnea has been used as laxative and anti-worm. Moreover, brew of dermal tissue are used for 
cough, respiratory distress and paregoric [9].  
 
The present study aims to evaluate the antifungal effects of methanolic and aqueous extract of A. eburnea against 
some fungal pathogenic strains such as Aspergillus flavus and Candida albican to detect new sources of antifungal 
agents. 
MATERIALS AND METHODS 
 
Collection of plant materials 
The shell root of A. eburnean was collected from rural regions of from Baft district, south east of Iran, in April 2013. 
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They were identified by a botanist of the Botany Department of Shahid Bahonar University, Kerman, Iran [10]. A 
voucher specimen of the plant materials was deposited at the Herbarium of Department of Pharmacognosy of School 
of Pharmacy, Kerman University of Medical Science, Iran (KF 1136). 
 
Preparing of extracts  
One hundred gram of powdered plant material was separately extracted by percolation method with methanol (80%) 
and water successively for 72 h. in room temperature. The extracts were passed through filter paper (Whatman No.3, 
Sigma, Germany) to remove plant debris. The extracts were finally concentrated in vacuum at 50°C using a rotary 
evaporator (Heidolph, Germany) and stored at -20°C, until testing [11, 12].  
 
Antibacterial Activity 
Microorganisms 
Fungal pathogenic strains including Aspergillus flavus (ATTCC 15546) and Candida albican (ATCC 10321) were 
used for the experiment. 
 
Cultivation of fungi 
The fungi were grown on Sabouraud Dextrose Agar (SDA) slants at 28°C for 7 days. After complete growth the 
spores were collected using sterile ice cold doubled distilled water and homogenized for the antifungal study [13]. 
 
Minimum Inhibitory Concentration (MIC) 
The minimum inhibitory concentration of the compound was performed according to the reference method 
described elsewhere [14, 15]. The extracts were dissolved in water together with 2% dimethyl sulfoxide (DMSO). 
The initial test concentration (0.5 mg/mL) was serially diluted twofold to obtain the extracts at the concentrations 
0.5-16 mg/mL. Each well was inoculated with 5 µL of suspension containing 104 spore/mL of fungi, respectively. 
The plates were incubated for 24-72 h at 30°C. Ketoconazole and DMSO were also used as positive and negative 
control, respectively. Five µL of tested broth was placed on the sterile MHA plates and sealed in plastic bags to 
avoid contamination in the laboratory and at respective temperature. The MICs were calculated after an incubation 
time with no visible growth. The experiment was conducted in triplicate. 
 
Statistical analysis 
All the tests were performed in triplicate. Data analysis was carried out by using SPSS statistical package version 
17.0 (SPSS Inc., Chicago, IL, USA). Differences between test and control groups were analyzed by t-test. In 
addition, p<0.05 was considered statistically significant [16, 17]. 
 
Table 1. Mean of minimum inhibitory concentration (MIC) of Amygdalus eburnea extracts against some pathogenic fungi strains 
 
Tested sample 
(mg/ml) 
Bacterial strain 
Aspergillus flavus Candida albican 
Methanolic extract 9.33 5.33 
Aqueous extract 13.33 7.33 
Ketoconazol 0.5 0.5 
 
RESULTS AND DISCUSSION 
 
Table 1 shows the results of in vitro antifungal assay of A. eburnean extracts. Both aqueous and menthanolic extract 
of A. eburnea at all concentration demonstrated fungistatic activity against the tested fungi from week to potent with 
the MIC ranging from 5.33 to 9.33 mg/mL and 7.3 to 13.33 mg/mL, respectively. Methanolic extracts significantly 
(p<0.05) were much more effective than aqueous extract of A. eburnea once it exhibited lower MIC values for all 
the fungi. Among the tested fungi pathogens, C. albicans was the most sensitive to the extracts of A. eburnean. 
Moreover, ketoconazole as control drugs exhibited antifungal activities with the MIC 0.5 mg/ml tested fungi 
pathogens.  
 
With the advent of industrial and synthetic antimicrobial agents in the middle of last century, lack of interest in 
plants as a natural and valuable source for antimicrobial drugs was caused [18]. Recently, with the emergence of 
some limitations in the use of these drugs, the situation has shifted and field of ethnobotanical research has been 
expanded [19]. The present study showed that A. eburnean extract was capable of inhibiting the growth of fungi 
strains that are as most common opportunist fungi. Approximately in phytochemical screening of the crude extract 
of all of plants there are some compounds such as terpenoids, phenols, flavonoids, fatty acids and sterols [19]. In 
several investigations biological especially antimicrobial activities of these components have been proven [20-24]. 
Thus, we can suggest that these components are responsible for the antifungal activity of A. eburnean; however their 
exact action mechanism is poorly understood. To conclude, the obtained findings demonstrated that A. eburnean 
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extracts were found to be more active against some pathogenic fungi strains and thus provided the evidence for its 
traditional use value and it is suitable substitute for treatment of fungi infections. 
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